Hydrogen Future (HFCO) 10-Q 14 Feb 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Dec. 31, 2013	Feb. 12, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Hydrogen Future Corp	'
Entity Central Index Key	'0001381054	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--09-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	109,607,020
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Assets	'	'
Cash	$0	$0
Other receivables	3,194	3,194
Total current assets	3,194	3,194
Property and equipment - net	191,034	199,567
Debt issue costs - net	12,406	15,983
Total assets	206,634	218,744
Liabilities and Stockholders' (Deficit)	'	'
Accounts payable and accrued liabilities	122,610	122,610
Accounts payable - related party	415,719	415,719
Accrued interest payable	95,396	74,247
Notes/Advances payable - related party	27,173	27,173
Common stock to be issued	45,000	'
Derivative liability	48,939	1,337,315
Convertible debt - net	705,882	591,738
Total current liabilities	1,460,719	2,568,801
Stockholders' (Deficit)	'	'
Preferred stock, $0.001 par value, 200,000,000 shares authorized; 100,000,000 issued and outstanding	100,000	100,000
Common stock, $0.001 par value, 10,000,000,000 shares authorized; 510,498,832 and 100,000,000 issued and outstanding	510,499	100,000
Additional paid-in capital	2,514,433	2,609,577
Deficit accumulated during the development stage	-4,379,522	-5,160,139
Accumulated other comprehensive income	505	505
Total stockholders' (deficit)	-1,254,086	-2,350,057
Total liabilities and stockholders' (deficit)	$206,634	$218,744

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Statement of Financial Position [Abstract]	'	'
Preferred Stock Par Value	$0.00	$0.00
Preferred Stock Authorized	200,000,000	200,000,000
Preferred Stock Issued	100,000,000	100,000,000
Preferred Stock Outstanding	100,000,000	100,000,000
Common Stock Par Value	$0.00	$0.00
Common Stock Authorized	10,000,000,000	10,000,000,000
Common Stock Issued	510,498,832	100,000,000
Common Stock Outstanding	510,498,832	100,000,000

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended		84 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Expenses	'	'	'
General and Administrative Expenses	$229,986	$235,092	$2,833,928
Impairment of software	'	'	1,035,027
Total	229,986	235,092	3,868,955
Other (Expense)	'	'	'
Interest expense	-103,510	-114,777	-634,675
Derivative expense	-1,052,177	-137,631	-2,620,067
Change in fair value of derivative liability	2,340,552	223,150	3,084,726
Loss on Retirement of Debt	-174,263	'	-376,623
Tax refunds	'	'	36,071
Total Other (Expense) - net	1,010,603	-29,258	-510,568
Net Income (Loss)	$780,617	$694,279	($4,379,522)
Net loss per common share - basic	$0.00	($0.00)	'
Net loss per common share - diluted	$0.00	($0.00)	'
Weighted average number of common shares outstanding during the period/year - basic	252,805,020	60,779,150	'
Weighted average number of common shares outstanding during the period/year - diluted	352,805,020	60,779,150	'

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		84 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'	'
Net loss	$780,617	$694,279	($4,379,522)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'	'
Share based payments	'	30,000	652,549
Impairment of software	'	'	1,035,027
Derivative expense	1,052,177	144,581	2,620,067
Depreciation	8,533	34,130	443,615
Amortization of debt issue cost	3,578	9,886	38,495
Amortization of debt discount	81,462	169,512	515,765
Amortization of Original Issue Discount	899	'	1,015
Change in fair value of derivative liabilities	-2,340,552	-223,150	-3,084,726
Accrued interest on Retired debt	'	'	779
Legal fees on debt conversions	2,875	'	2,875
Common stock to be issued	45,000	'	45,000
Loss on Retirement of Debt	174,263	'	376,623
Changes in operating assets and liabilities:	'	'	'
(Increase) decrease in other receivables	'	77,321	-3,194
Increase (decrease) in accounts payable and accrued expense	'	-18,054	122,610
Increase in accounts payable - related party	'	133,249	415,719
Increase in accrued interest	21,149	26,624	95,396
Net cash provided by (used in) operating activities	-170,000	-85,000	-1,101,908
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'	'
Purchase of property and equipment	'	'	-288,799
Net cash used in investing activities	'	'	-288,799
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'	'
Proceeds from related party notes/advances	'	'	31,586
Proceeds from convertible notes payable	95,000	40,303	463,803
Notes Issued for Professional services	75,000	53,727	343,727
Repayment of related party notes/advances	'	'	-968
Cash paid as debt offering costs	'	'	-24,000
Proceeds from issuance of common stock	'	'	579,500
Net cash provided by financing activities	170,000	94,030	1,393,648
Net (Decrease) in Cash	0	9,030	2,941
Effect of Exchange Rates on Cash	'	-9,096	-2,941
Cash - Beginning of Period/Year	0	854	'
Cash - End of Period/Year	0	788	0
Interest	'	'	'
Income Taxes	'	'	'
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'
Debt converted to common shares	138,217	'	111,484
Common stock issued to acquire software	'	'	1,380,876
Preferred stock issued to officers	310,000	'	310,000
Debt discount recorded on convertible debt accounted for as a derivative liability	170,000	300,000	300,000
Debt discount recorded on convertible debt accounted for as a derivative liability - original issue discount	'	27,122	27,122
Debt issue costs - warrants	'	$26,901	$26,901

Statement_of_Stockholders_Equi

Statement of Stockholder's Equity (USD $)	Common Stock	Preferred Stock	Additional Paid-In Capital	Deficit Acquired During Development Stage	Accumulated Other Comprehensive Income / Loss	Total
Beginning Balance, Amount at Jun. 20, 2006	$0	$0	$0	$0	$0	$0
Beginning Balance, Shares at Jun. 20, 2006	0	'	'	'	'	'
Proceeds from the Issuance of common stock, shares	25,000,000	'	'	'	'	'
Proceeds from the Issuance of common stock, amount	25,000	'	-5,000	'	'	20,000
Net loss	'	'	'	-2,631	0	-2,631
Ending Balance, Amount at Sep. 30, 2006	25,000	0	-5,000	-2,631	0	17,369
Ending Balance, shares at Sep. 30, 2006	25,000,000	'	'	'	'	'
Proceeds from the Issuance of common stock, shares	20,500,000	'	'	'	'	'
Proceeds from the Issuance of common stock, amount	20,500	'	61,500	'	'	82,000
Net loss	'	'	'	-16,960	0	-16,960
Ending Balance, Amount at Sep. 30, 2007	45,500	0	56,500	-19,591	0	82,409
Ending Balance, shares at Sep. 30, 2007	45,500,000	'	'	'	'	'
Net loss	'	'	'	-18,199	'	-18,199
Ending Balance, Amount at Sep. 30, 2008	45,500	'	56,500	-37,790	0	64,210
Ending Balance, shares at Sep. 30, 2008	45,500,000	'	'	'	'	'
Net loss	'	'	'	-19,076	0	-19,076
Ending Balance, Amount at Sep. 30, 2009	45,500	0	56,500	-56,866	0	45,134
Beginning Balance, Shares at Sep. 30, 2009	45,500,000	'	'	'	'	'
Proceeds from the Issuance of common stock, shares	500,000	'	'	'	'	'
Proceeds from the Issuance of common stock, amount	500	'	362,000	0	0	362,500
Common stock issued for consulting services, shares	170,000	'	'	'	'	'
Common stock issued for consulting services, amount	170	'	150,830	0	0	151,000
Foreign currency translation adjustment	'	'	'	'	-3,079	-3,079
Common stock issued to acquire software, shares	1,569,177	'	'	'	'	'
Common stock issued to acquire software, amount	1,569	'	1,379,307	'	'	1,380,876
Net loss	'	'	'	-351,790	0	-351,790
Ending Balance, Amount at Sep. 30, 2010	47,739	'	1,948,637	-408,656	-3,079	1,584,641
Ending Balance, shares at Sep. 30, 2010	47,739,177	'	'	'	'	'
Proceeds from the Issuance of common stock, shares	387,500	'	'	'	'	'
Proceeds from the Issuance of common stock, amount	387	'	114,613	0	0	115,000
Foreign currency translation adjustment	'	'	'	'	9,234	9,234
Debt discount on convertible notes - Original Issue Discount	'	'	27,122	'	'	27,122
Debt issue costs - warrants	'	'	26,901	'	'	26,901
Shares issued for conversion of note, shares	1,120,000	'	'	'	'	'
Shares issued for conversion of note, amount	1,120	'	23,870	'	'	24,990
Net loss	'	'	'	-3,024,617	'	-3,024,617
Ending Balance, Amount at Sep. 30, 2011	49,247	'	2,141,143	-3,433,273	6,155	-1,236,728
Ending Balance, shares at Sep. 30, 2011	49,246,677	'	'	'	'	'
Foreign currency translation adjustment	'	'	'	'	-5,650	-5,650
Share rescission, shares	-2,808,176	'	'	'	'	'
Share rescission, amount	-2,808	'	-87,128	'	'	-89,936
Net loss	'	'	'	694,279	'	694,279
Ending Balance, Amount at Sep. 30, 2012	46,438	'	2,050,415	-2,738,994	505	-638,036
Ending Balance, shares at Sep. 30, 2012	46,438,491	'	'	'	'	'
Common stock issued for consulting services, shares	145,897	'	'	'	'	'
Common stock issued for consulting services, amount	146	'	306	'	'	452
Shares issued for conversion of note, shares	5,954,252	'	'	'	'	'
Shares issued for conversion of note, amount	5,954	'	231,620	'	'	237,575
Share Issuance upon default of debt, shares	15,000,000	'	'	'	'	'
Share Issuance upon default of debt, amount	15,000	'	43,500	'	'	58,500
Issuance of Shares to Officers for Compensation, shares	32,061,360	'	'	'	'	'
Issuance of Shares to Officers for Compensation, amount	32,061	'	70,535	'	'	102,596
Common stock issued upon conversion of insider debt, shares	400,000	'	'	'	'	'
Common stock issued upon conversion of insider debt, amount	400	'	-400	'	'	0
Issuance of Preferred Stock to Officers, shares	'	100,000,000	'	'	'	'
Issuance of Preferred Stock to Officers, amount	'	100,000	210,000	'	'	310,000
Net loss	'	'	'	-2,421,145	'	-2,421,145
Ending Balance, Amount at Sep. 30, 2013	100,000	100,000	2,609,577	-5,160,139	505	-2,350,057
Ending Balance, shares at Sep. 30, 2013	100,000,000	100,000,000	'	'	'	'
Debt issue costs - warrants	'	'	'	'	'	'
Shares issuance upon conversion of debt and legal expense, shares	410,498,832	'	'	'	'	'
Shares issuance upon conversion of debt and legal expense, amount	410,499	'	-95,144	'	'	315,355
Net loss	'	'	'	'	'	780,607
Ending Balance, Amount at Dec. 31, 2013	$510,499	$100,000	$2,514,433	($4,379,522)	$505	($1,254,086)
Ending Balance, shares at Dec. 31, 2013	510,498,832	100,000,000	'	'	'	'

1_Basis_of_Presentation

1. Basis of Presentation	3 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
1. Basis of Presentation	'
	The accompanying unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission for interim financial information.
	The financial information as of September 30, 2013 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the years ended September 30, 2013 and 2012.  The unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, which contains the audited financial statements and notes thereto, together with the Management’s Discussion and Analysis, for the years ended September 30, 2013 and 2012.
	Certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The interim results for the three months ended December 31, 2013 are not necessarily indicative of results for the full fiscal year.

2_Nature_of_Operations_and_Sum

2. Nature of Operations and Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
2. Nature of Operations and Summary of Significant Accounting Policies	'
	Nature of Operations
	HYDROGEN FUTURE CORP., (the “Company”) was incorporated in the State of Nevada on June 21, 2006. The Company was originally incorporated as El Palenque Nercery, Inc. and changed its name to El Palenque Vivero, Inc. on December 31, 2006. On March 23, 2010, it further changed its name to A5 Laboratories Inc. On October 10, 2013, we changed our name to Hydrogen Future Corporation. On December 27, 2013, our stock trading symbol was changed from AFLB.OB to HFCO.OB.  Our business offices are located at 2525 Robinhood Street,  Suite 1100, Houston TX and our telephone number is (713) 465-1001.
	The Company intends to provide contract research and laboratory services to the pharmaceutical industry. To date, the activities of the Company have been limited to raising capital.
	The Company’s fiscal year end is September 30.
	Development Stage
	The Company's financial statements are presented as those of a development stage enterprise. Activities during the development stage primarily include equity based financing and further implementation of the business plan.
	Risks and Uncertainties
	The Company intends to operate in an industry that is subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, regulatory and other risks, including the potential risk of business failure.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
	Such estimates for the periods ended December 31, 2013 and 2012, and assumptions affect, among others, the following:
	●	estimated carrying value, useful lives and impairment of property and equipment;
	●	estimated fair value of derivative liabilities;
	●	estimated valuation allowance for deferred tax assets; and
	●	estimated fair value of share based payments
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.
	Cash and Cash Equivalents
	The Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. At December 31, 2013 and September 30, 2013, the Company had no cash equivalents.
	The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At December 31, 2013 and September 30, 2013, there were no balances that exceeded the federally insured limit.
	Property and Equipment
	Property and equipment (including related party purchases) is stated at cost, less accumulated depreciation computed on a straight-line basis over the estimated useful lives. Maintenance and repairs are charged to operations when incurred.  Betterments and renewals are capitalized when deemed material.  When property and equipment are sold or otherwise disposed of, the asset account and related accumulated depreciation account are relieved, and any gain or loss is included in operations.
	Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  The Company recognized an impairment of $1,035,027 during the year ended September 30, 2011.  See Note 6.
	Beneficial Conversion Feature
	For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount.
	When the Company records a BCF, the relative fair value of the BCF would be recorded as a debt discount against the face amount of the respective debt instrument.  The discount would be amortized to interest expense over the life of the debt.
	Derivative Liabilities
	Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes.  In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model.  In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement.  If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.
	Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.  In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.
	Debt Issue Costs and Debt Discount
	The Company paid debt issue costs, and recorded debt discounts in connection with raising funds through the issuance of convertible debt.  These costs are amortized over the life of the debt to interest expense.  When a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.
	Original Issue Discount
	For certain convertible debt issued, the Company provides the debt holder with an original issue discount (“OID”).  An OID is the difference between the original cash proceeds and the amount of the note upon maturity. The Note is originally recorded for the proceeds received. The OID is expensed into interest expense pro-rata over the term of the Note, and upon maturity, the Note shall equal the proceeds due.
	Share-Based Payments
	Generally, all forms of share-based payments, including stock option grants, warrants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on estimated number of awards that are ultimately expected to vest.  Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments are recorded as a component of general and administrative expense.
	Earnings per Share
	Basic earnings (loss) per share is computed by dividing net income (loss) by weighted average number of shares of common stock outstanding during each period.  Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.
	Prior to the issuance of the Company’s Preferred Stock during the calendar year ending September 30, 2013, the Company did not have any dilutive securities.  As such, a separate computation of diluted earnings (loss) per share was not presented. Commencing with the issuance of the Preferred Stock, the Company now has dilutive securities, and a separate computation of diluted earnings (loss) per share is now presented.
	The Company had the following potential common stock equivalents at December 31, 2013 and September 30, 2013:
			31-Dec-13		September
					30, 2013
	Warrants (1)			7,894,737		7,894,737
	Convertible debt (1)			7,852,782,286
	Total common stock equivalents (2)			7,876,382,587		98,955,822
	(1)    The potential shares for which these instruments can convert into common stock currently exceed the Company’s authorized shares for common stock.  The Company has identified a debt and warrant holder who cannot exceed ownership in the Company by 9.99%.  The investor is limited to 10,960,702 shares on a fully diluted basis, which is the Company’s maximum exposure at the balance sheet date.
	(2)    There are other warrant holders included in total warrants besides those described in note (1) above.
	Fair Value of Financial Instruments
	The carrying amounts of the Company’s short-term financial instruments, other receivables, accounts payable and accrued liabilities, approximate fair value due to the relatively short period to maturity for these instruments.
	Foreign Currency Transactions
	The Company’s functional currency is the Canadian Dollar.  The Company’s reporting currency is the U.S. Dollar.  All transactions initiated in Canadian Dollars are translated to U.S. Dollars in accordance with ASC 830-10-20 “Foreign Currency Translation” as follows:
	(i)	Monetary assets and liabilities at the rate of exchange in effect at the balance sheet date;
	(ii)	Equity at historical rates; and
	(iii)	Revenue and expense items at the average exchange rate prevailing during the period.
	Adjustments arising from such translations are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income (loss).  Therefore, translation adjustments are not included in determining net income (loss) but reported as other comprehensive income (loss).
	For foreign currency transactions, the Company translates these amounts to the Company’s functional currency at the exchange rate effective on the invoice date.  If the exchange rate changes between the time of purchase and the time actual payment is made, a foreign exchange transaction gain or loss results which is included in determining net income for the period.
	Comprehensive Income (Loss)
	Comprehensive income or loss is comprised of net earnings or loss and other comprehensive income or loss, which includes certain changes in equity, excluded from net earnings, primarily foreign currency translation adjustments.
	Foreign Country Risks
	The Company may be exposed to certain risks as its operations are being conducted in Canada.  The Company’s results may be adversely affected by change in the political and social conditions in Canada due to governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversions and remittances abroad, and rates and methods of taxation, among other things.  The Company does not believe these risks to be significant, and no such losses have occurred in the current or prior periods because of these factors.  However, there can be no assurance those changes in political and other conditions will not result in any adverse impact in future periods.
	Recent Accounting Pronouncements
	In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. The guidance in ASU 2011-04 changes the wording used to describe the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements, including clarification of the FASB's intent about the application of existing fair value and disclosure requirements and changing a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The amendments in this ASU should be applied prospectively and are effective for interim and annual periods beginning after December 15, 2011. Early adoption by public entities is not permitted. The adoption of this guidance is not expected to have a material impact on the Company’s financial position or results of operations.
	In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. The guidance in ASU 2011-05 applies to both annual and interim financial statements and eliminates the option for reporting entities to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This ASU also requires consecutive presentation of the statement of net income and other comprehensive income. Finally, this ASU requires an entity to present reclassification adjustments on the face of the financial statements from other comprehensive income to net income. The amendments in this ASU should be applied retrospectively and are effective for fiscal year, and interim periods within those years, beginning after December 15, 2011. The Company has adopted this guidance in these financial statements.

3_Going_Concern

3. Going Concern	3 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
3. Going Concern	'
	As reflected in the accompanying financial statements, the Company had net income of $780,607 for the three months ended December 31, 2013, but we utilized $170,000 in cash for our operations. The Company also has a working capital deficit of $1,457,525 and a deficit accumulated during the development stage of $4,379,522 at December 31, 2013. In addition, the Company is in the development stage and has not yet generated any revenues. These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The ability of the Company to continue its operations is dependent on Management's plans, which include potential asset acquisitions, mergers or business combinations with other entities, further implementation of its business plan and continuing to raise funds through debt or equity raises. The Company will likely rely upon equity financing in order to ensure the continuing existence of the business.
	The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
	These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

4_Fair_Value_of_Financial_Asse

4. Fair Value of Financial Assets and Liabilities	3 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
4. Fair Value of Financial Assets and Liabilities	'
	The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.
	The following are the hierarchical levels of inputs to measure fair value:
	·	Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
	·	Level 2: Inputs reflect: quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	·	Level 3: Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
	At December 31, 2013, the fair value of financial instruments measured on a recurring basis includes derivative liabilities, determined based on level two inputs consisting of quoted prices in active markets for identical assets. The carrying amount reported for accounts payable, accrued liabilities, and notes payable approximates fair value because of the short-term maturity of these financial instruments.
	The Company has a derivative liability measured at fair market value on a recurring basis. Consequently, the Company had changes in fair value reported in the statements of operations, which were attributable to the change in market value relating to the liability for the three months ended December 31, 2012.
	The following is the Company’s derivative liability measured at fair value on a recurring basis at:
			31-Dec-13		30-Sep-13
	Level 1		$	-	$	-
	Level 2 – Derivative Liability			48,939		1,337,315
	Level 3			-		-
	Total		$	48,939	$	1,337,315

5_Other_Receivables

5. Other Receivables	3 Months Ended
	Dec. 31, 2013
Receivables [Abstract]	'
5. Other Receivables	'
	As of December 31, 2013 and September 30, 2013, the Company had receivables of $3,194. The receivable was for amounts funded to a company controlled by our Chief Executive Officer.

6_Property_and_Equipment

6. Property and Equipment	3 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
6. Property and Equipment	'
	Property and equipment consists of the following:
		31-Dec-13			30-Sep-13			Estimated Useful Lives
	Software	$	-		$	1,380,876			3
	Leasehold improvements (1)		144,802			144,802			10
	Lab equipment (2)		106,062			106,705			10
	Office equipment		37,336			37,336			5
			288,843			1,669,719
	Less: Accumulated depreciation		(97,809	)		(435,125	)
	Less: Impairment		-			(1,035,027	)
	Property and equipment – net	$	191,034		$	199,567
	(1)    See Note 8(B) – related party
	(2)    See below related to related party purchases
	During the year ended September 30, 2011, management evaluated the recoverability of long lived assets by determining whether the carrying value can be recovered through future cash flows. Management determined that it is more likely than not that no future cash flows are to be expected from the use of its software. Due to these circumstances, the remaining book value of the asset in the amount of $1,035,027 was fully impaired and is included in the statements of operations for the year ended September 30, 2011.
	The leasehold improvements were completed and placed into service in July 2011.
	The Company purchased $104,122 of lab equipment from an entity controlled by the Company’s former Chief Executive Officer during fiscal years ended 2010 and 2011 as follows:
	2010	$	79,765
	2011		24,357
		$	104,122

7_Notes_Payable

7. Notes Payable	3 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
7. Notes Payable	'
	(A) Related Party
	The following is a summary of the Company’s related party liabilities:
			31-Dec-13				30-Sep-13
	Notes payable (1)		$	20,915			$	20,915
	Advances (2)			7,226				7,226
	Less: payments			(968	)			(968	)
	Total related party liabilities		$	27,173			$	27,173
	(1) The note is non-interest bearing, unsecured, and due on demand.
	(2) The advances are non-interest bearing, unsecured, and due on demand.
	(B) Convertible Debt – Secured – Derivative Liabilities
	Fife Note
	On February 15, 2011, the Company issued convertible notes, totaling $300,000, to John Fife with the following provisions:
	●	Interest rate 6%;
	●	Default interest rate of 12%;
	●	Notes are due 48 months from the issuance date of February 23, 2011;
	●	Conversion rates equal to 70% or 80% of the market price on date of conversion by applying a specified formula that utilizes the average of the 3 lowest quoted closing prices 20 days immediately preceding the conversion date, and then takes the higher of the average 3 lowest closing prices or $0.12 floor price; and
	●	Secured by the Chief Executive Officer’s 15,000,000 shares of the Company common stock.
	The investor is entitled at its option to convert all or part of the principal and accrued interest into shares of the Company’s common stock at a conversion price as discussed above.  The Company classified the embedded conversion feature as a derivative liability due to management’s assessment that the Company may not have sufficient authorized number of shares of common stock required to net-share settle.
	On February 23, 2011, the Company entered into asecured convertible promissory note between the Company and a third party (the “Lender”). The note balance totaled $300,000. The Lender expects to contribute funds in tranches, the first tranche being equal to $300,000, and an additional ten tranches equal to $200,000 each commencing on October 23, 2011, and continuing each subsequent month for ten months.  No additional draw downs occurred during the year ended September 30, 2011.  In January 2012, the Company received $22,000 from a lender for an additional investment, under the same terms above, which is convertible to shares pursuant to the terms described below. See Note 9(A) related to conversions of this $300,000 note.
	The number of shares of common stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the higher of (i) the Market Price or (ii) the Floor Price. Where “Market Price” is defined as 80% of the average of the closing bid price for the three (3) days with the lowest closing bids during the twenty trading days immediately preceding the conversion date, provided, however, that if the market prices fall below $0.05 per share of common stock the conversion factor shall be reduced by 10 percentage points.  The “Floor Price” is defined as $.012. The trading data used to compute the closing bid shall be as reported by Bloomberg, LP or if such information is not then being reported by Bloomberg, then as reported by such other data information sources as may be selected by the Lender.
	The note also contains language that removes the $0.12 floor if certain “triggering events” occur during the life of the note. Since the floor price can be removed upon any one of these events occurring, the conversion feature of this note has two elements: normal conversion and conversion upon a triggering event.
	Upon each occurrence of any of the following triggering events , (a) the conversion factor shall be reduced by 10 percent points (i.e., if the conversion factor were 80% immediately prior to the occurrence of the triggering event, it shall be reduced to 70% upon the occurrence of a triggering event), (b) the conversion price shall be computed without regard to the Floor Price, and (c) this note shall accrue interest at the rate of 1% per month, whether before or after judgment; provided, however, that (1) in no event shall the triggering effects be applied more than two times, and (2) notwithstanding any provisions to the contrary herein, in no event shall the applicable interest rate at any time exceed the maximum interest rate allowed under applicable law:
	On October 4, 2012, Mr. Fife foreclosed on his note to us because we were in default.  According to the terms of the indenture, Mr. Fife was issued 15 million shares to forestall on his claim against the firm.  At the time, the common stock of the Company was trading at $.0039.   Therefore, a corresponding expense of $58,500 was recorded at that time and included in General and Administrative Expense.
	As of December 31, 2013, as a result of the triggering events (a) and (b), the Company computes the exercise price related to convertible debt, without regard to the floor price.
	The normal conversion resulted in a debt discount under ASC 470-25-8 since the calculated market price as of the date of the note was higher ($0.145) than the conversion floor of $0.12.
	At the balance sheet date, $93,600 of the debt has been converted leaving a principal balance of $206,400.
	Lucosky Brookman LLP Note
	Effective on January 10, 2012, the Company issued to Lucosky Brookman LLP  (“Lucosky”) a convertible promissory note ( the “Lucosky Note”) for legal services provided since February 1, 2011 of $53,727.  The Lucosky Note bears interest at twelve percent (12%) per annum and has a term of six months.  Should the Lucosky Note not be paid by the Maturity Date, an event of Default occurs and the interest rate becomes eighteen percent (18%) per annum.  Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the average of the closing price for the five (5) days immediately preceding the conversion date.
	During the quarter ended December 31, 2013, $34,790 of the debt was converted into common stock.  $18,937 of principal value remains
	Consulting Notes
	During the last six months of the prior fiscal year, the Company issued notes totaling $215,000 to a consultant.  $165,000 of the Notes bear interest at twelve percent (12%) per annum and mature on June 30, 2014.    Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the low closing bid price for the five (5) days immediately preceding the conversion date.
	The remaining $125,000 of the Notes bear no interest and have a six month term.  Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the low closing bid price for the five (5) days immediately preceding the conversion date. These Notes are due in the second quarter of the Fiscal year ended September 30, 2014.
	St. George Notes
	On August 27, 2013, St. George Investments LLC (“St. George”) advanced the Company $12,500 (“St. George Note”).  The St. George Note has a one year term, an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The St. George Note has a face value of $13,750, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 60% of the average of the two (2) low closing bid prices for the ten (10) days immediately preceding the conversion date.
	On October 10, 2013, St. George Investments LLC (“St. George”) advanced the Company $15,000 (“St. George Note”).  The St. George Note has a one year term, an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The St. George Note has a face value of $13,750, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 60% of the average of the two (2) low closing bid prices for the ten (10) days immediately preceding the conversion date.
	On November 19, 2013, St. George Investments LLC (“St. George”) advanced the Company $10,000 (“St. George Note”).  The St. George Note has a one year term, an interest rate of ten percent and a ten percent original issue discount (“OID”).  An OID represents the difference between the amount received and the face value of the note.  The St. George Note has a face value of $13,750, and the OID will be amortized into expense pro-rata over the term of the Note. Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 60% of the average of the two (2) low closing bid prices for the ten (10) days immediately preceding the conversion date.
	Other Notes
	The Company has received another $111,000 in proceeds from multiple investors.  Shares of Common Stock to be issued upon conversion of each tranche shall be determined by dividing (a) the conversion amount by (b) the Market Price. The “Market Price” is defined as 50% of the low closing bid price for the twenty (20) days immediately preceding the conversion date.  There is no interest on these Notes. $11,000 of the Notes matures in the fiscal third quarter of 2014, $70,000 in the fourth quarter of fiscal 2014 and $30,000 matures in the fiscal second quarter of 2014.
	(C) Debt Issue Costs
	In connection with the issuance of the $300,000 note discussed above, the Company incurred debt issue costs as follows:
	·	8% cash – which is equivalent to $24,000, and
	·	8% warrants – having a fair value of $26,901, which was computed as follows;
			Commitment Date
	Expected dividends			0%
	Expected volatility			180%
	Expected term: conversion feature		2 years
	Risk free interest rate			1.73%
	In January 2012, we raised an additional $22,000 as discussed above, and the Company incurred debt issue costs as follows:
	·	8% cash – which is equivalent to $1,760, and
	·	8% warrants – having a fair value of $154, which was computed as follows;
			Commitment Date
	Expected dividends			0%
	Expected volatility			364%
	Expected term: conversion feature		2 years
	Risk free interest rate			0.65%
	The debt issue costs have been capitalized and are being amortized over the life of the note.
	Debt issue costs paid, September 30, 2011			$	50,901
	Amortization of debt issue costs, September 30, 2011				(11,833	)
	Amortization of debt issue costs, September 30, 2012				(9,833	)
	Amortization of debt issue costs, September 30, 2013				(13,199	)
	Amortization of debt issue costs, December 31, 2012				(3,577
	Debt issue costs - net			$	12,406
	(D) Debt Discount
During the three months ended December 31, 2013 and December 31, 2012, Company recorded debt discounts totaling $170,000 and $165,000, respectively.
The debt discount recorded in the current quarter pertains to convertible debt containing embedded conversion options that are required to bifurcated and reported at fair value.
During the three months ended December 31, 2013, the Company amortized $81,462 in debt discount.

8_Liability_for_Common_Stock_t

8. Liability for Common Stock to be Issued	3 Months Ended
	Dec. 31, 2013
Notes to Financial Statements	'
8. Liability for Common Stock to be Issued	'
	On December 20, 2013, the Company agreed to issued 360 million shares pre-split (720,000 shares post-split) to the three directors.  Based upon the price of the shares on that date of $.000125 pre-split ($.0625 post-split), a liability of $45,000 was established. These shares were not issued until January 2014.  At that time, the liability was extinguished.

9_Stockholders_Equity_Deficit

9. Stockholders Equity (Deficit)	3 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
9. Stockholdersb Equity (Deficit)	'
	A) Common Stock
	Stock Issued in 2014
	During the quarter ended December 31, 2013, the Company issued 410,498,832 shares for the conversion of shares of common stock.
	Stock Issued in 2013
	On February 19, 2013, the Company issued 5,954, 252 shares for the conversion of $15,000 of debt plus accrued interest.
	On December 31, 2012, the Company issued 15,000,000 shares of common stock to John Fife for the default on his Note. See Footnote 6
	The Company issued 32,061,360 shares for compensation to Directors and Officers
	Stock issued in 2012
	On October 2, 2011, a lender converted $50,000 pertaining to a note it held with an original principal of $300,000, for 3,000,000 shares of common stock ($0.0166667/share).   The quantity of shares issued is based upon the formula described above pertaining to the effect of the triggering event (see Note 7(B)).
	On January 3, 2012, the Company issued 2,307,692 shares of common stock for $30,000 ($0.013/share) for services rendered.
	On March 4, 2012, a lender converted $21,494 pertaining to a note it held with an original principal of $300,000, for 3,800,000 shares of common stock ($0.00566/share).   The quantity of shares issued is based upon the formula described above pertaining to the effect of the triggering event (see Note 7(B)).
	Stock issued 2011
	During November and December 2010, the Company issued 312,500 shares of common stock for $100,000 ($0.32/share).
	On June 14, 2011, the Company issued 75,000 shares of common stock for $15,000 ($0.20/share).
	On September 2, 2011, a lender converted $24,990 pertaining to a note it held with an original principal of $300,000, for 1,120,000 shares of common stock ($0.022313/share).  The quantity of shares issued is based upon the formula described above pertaining to the effect of the triggering event (see Note 7(B)).
	Stock issued in 2010
	On March 9, 2010, the Company’s board of directors authorized a 10-for-1 forward split of its common stock effective April 8, 2010.  Each stockholder of record on April 7, 2010 received ten new shares of the Company’s $0.001 par value common stock for every one old share outstanding.  The effects of the split have been retroactively applied to all periods presented in the accompanying financial statements.
	On June 3, 2010, the Company issued 250,000 shares of common stock for $162,500 ($0.65/share).
	On July 20, 2010, the Company issued 1,569,177 shares of common stock, having a fair value of $1,380,876 ($0.88/share), based upon the closing trading price, to acquire software from an affiliate of the Company’s Chief Executive Officer.
	On July 30, 2010, the Company issued 125,000 shares of common stock for $100,000 ($0.80/share). In addition, the stockholder received a 2-year warrant for 125,000 shares with an exercise price of $1.20.
	On August 18, 2010, the Company issued 125,000 shares of common stock for $100,000 ($0.80/share). In addition, the stockholder received a 2-year warrant for 125,000 shares with an exercise price of $1.20.
	On August 23, 2010, the Company issued 20,000 shares of common stock to a consultant, having a fair value of $16,000 ($0.80/share), based upon the closing trading price.  At September 30, 2010, the Company expensed this stock issuance as a component of general and administrative expense.
	On September 17, 2010, the Company issued 150,000 shares of common stock to a consultant, having a fair value of $135,000 ($0.90/share), based upon the closing trading price.  At September 30, 2010, the Company expensed this stock issuance as a component of general and administrative expense.
	Stock issued in 2007
	During 2007, the Company issued 20,500,000 shares of common stock for $82,000 ($0.004/share).
	Stock Issued in 2006
	On June 21, 2006 (Inception), the Company issued 10,000,000 shares of common stock for $5,000 ($0.0005/share) to directors and officers of the Company.
	On August 1, 2006, the Company issued 15,000,000 shares of common stock for $15,000 ($0.0001/share) to directors and officers of the Company.
	(B) Stock Warrants
	The following is a summary of the Company’s warrants that are outstanding and exercisable at December 31, 2012 and 2011:
				Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years
								Intrinsic Value
		Warrants
	Balance – September 30, 2011		1,074,000	$	0.3		1.27	$	8,560
	Granted		-		-		-		-
	Forfeited/Cancelled		-		-		-		-
	Exercised		-		-
	Balance – December 31, 2012 - outstanding		1,074,000	$	0.3		0.52	$	-
	Balance – December 31, 2012 - exercisable		1,074,000	$	0.3		0.52	$	-

10_Commitments_and_Contingenci

10. Commitments and Contingencies	3 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
10. Commitments and Contingencies	'
	(A) Contingencies
	From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse affect on its business, financial condition or operating results.
	(C) Equipment Lease
	The Company had agreed to rent equipment from its former Chief Executive.
	Rental equipment expense for the six months ended December 31, 2012 and 2011 was $-0- and $24,566, respectively.

11_Derivative_Liabilities

11. Derivative Liabilities	3 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
11. Derivative Liabilities	'
	The Company identified conversion features embedded within convertible debt ($300,000) issued in 2011 (see 7(B)). The Company has determined that the features associated with the embedded conversion option should be accounted for at fair value as a derivative liability.
	As a result of the application of ASC No. 815, the fair value of the conversion feature is summarized as follows:
	Derivative liability balance at September 30, 2013	$	1,337,315
	Derivative liability Fair value at the commitment date for convertible notes issued
	Fair value mark to market adjustment – December 31, 2013		(1,052,177
	Derivative liability associated with new issuances through December 31, 2013		(2,340,552	)
	Derivative liability balance at December 31, 2013	$	49,939
	The Company recorded the derivative liability to debt discount to the extent of the gross proceeds raised, and expensed immediately the remaining value of the derivative as it exceeded the gross proceeds of the note.  The Company recorded a derivative expense of $0 for the three months ended December 31, 2011.
	The fair value at the commitment and remeasurement dates were based upon the following management assumptions:
		23-Feb-11			31-Dec-12
		Commitment Date			Remeasurement Date
	Expected dividends		0%		0%
	Expected volatility		180%		298%
	Expected term: conversion feature	4 years			2.65 years
	Risk free interest rate		1.73%		0.25%

12_Other_Related_Party_Transac

12. Other Related Party Transactions	3 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
12. Other Related Party Transactions	'
	The Company accrues consulting and rental fees to its former Chief Executive Officer as follows:
	Balance at September 30, 2013 and December 31, 2013	$	415,719
	The consulting and rental fees are components of general and administrative expenses.

13_Subsequent_Events

13. Subsequent Events	3 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
13. Subsequent Events	'
	The Company has evaluated events subsequent to the balance sheet date through the issuance date of these financial statements in accordance with FASB ASC 855 and has determined the following would require disclosure in, the financial statements;
	Issuance of Shares
	In January 2014, 360 million shares of common stock (pre-split) were issued to the Management team.  See Note 8, for details
	Reverse Split of Shares
	On December 31, 2013, the Company approved a one for five hundred (1:500) reverse split of the outstanding shares of the Company’s common stock. The Amendment to the Company’s Articles of Incorporation was filed on January 10, 2014, with the Secretary of state of Nevada.  The reverse split became effective on January 27, 2014, and the Company’s new symbol became HFCOD. This will last for a period of 20 days until it will revert back to HFCO.  Please see our form 8-K filed on January 24, 2014 for more detail.
	Issuance of Shares
	On January 27, 2014, the Company issued to Management one hundred million (100,000,000) shares of post-split common shares to Management.  Please see our Form 8-K filed on January 28, for more detail.
	Conversion of Debt
	From the balance sheet date until the date of this report, the Company issued 7,693,218 shares for the conversion of $73,420 in convertible debt and $2,480 in legal fees

2_Nature_of_Operations_and_Sum1

2. Nature of Operations and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Nature of Operations	'
	HYDROGEN FUTURE CORP., (the “Company”) was incorporated in the State of Nevada on June 21, 2006. The Company was originally incorporated as El Palenque Nercery, Inc. and changed its name to El Palenque Vivero, Inc. on December 31, 2006. On March 23, 2010, it further changed its name to A5 Laboratories Inc. On October 10, 2013, we changed our name to Hydrogen Future Corporation. On December 27, 2013, our stock trading symbol was changed from AFLB.OB to HFCO.OB.  Our business offices are located at 2525 Robinhood Street,  Suite 1100, Houston TX and our telephone number is (713) 465-1001.
	The Company intends to provide contract research and laboratory services to the pharmaceutical industry. To date, the activities of the Company have been limited to raising capital.
	The Company’s fiscal year end is September 30.
Development Stage	'
	The Company's financial statements are presented as those of a development stage enterprise. Activities during the development stage primarily include equity based financing and further implementation of the business plan.
Risks and Uncertainties	'
	The Company intends to operate in an industry that is subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, regulatory and other risks, including the potential risk of business failure.
Use of Estimates	'
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
	Such estimates for the periods ended December 31, 2013 and 2012, and assumptions affect, among others, the following:
	●	estimated carrying value, useful lives and impairment of property and equipment;
	●	estimated fair value of derivative liabilities;
	●	estimated valuation allowance for deferred tax assets; and
	●	estimated fair value of share based payments
	Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.
Cash and Cash Equivalents	'
	The Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. At December 31, 2013 and September 30, 2013, the Company had no cash equivalents.
	The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At December 31, 2013 and September 30, 2013, there were no balances that exceeded the federally insured limit.
Property and Equipment	'
	Property and equipment (including related party purchases) is stated at cost, less accumulated depreciation computed on a straight-line basis over the estimated useful lives. Maintenance and repairs are charged to operations when incurred.  Betterments and renewals are capitalized when deemed material.  When property and equipment are sold or otherwise disposed of, the asset account and related accumulated depreciation account are relieved, and any gain or loss is included in operations.
	Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  The Company recognized an impairment of $1,035,027 during the year ended September 30, 2011.  See Note 6.
Beneficial Conversion Feature	'
	For conventional convertible debt where the rate of conversion is below market value, the Company records a “beneficial conversion feature” (“BCF”) and related debt discount.
	When the Company records a BCF, the relative fair value of the BCF would be recorded as a debt discount against the face amount of the respective debt instrument.  The discount would be amortized to interest expense over the life of the debt.
Derivative Liabilities	'
	Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes.  In determining the appropriate fair value, the Company uses the Black-Scholes option-pricing model.  In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement.  If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments.
	Once determined, derivative liabilities are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.  In addition, the fair value of freestanding derivative instruments such as warrants, are also valued using the Black-Scholes option-pricing model.
Debt Issue Costs and Debt Discount	'
	The Company paid debt issue costs, and recorded debt discounts in connection with raising funds through the issuance of convertible debt.  These costs are amortized over the life of the debt to interest expense.  When a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.
Original Issue Discount	'
	For certain convertible debt issued, the Company provides the debt holder with an original issue discount (“OID”).  An OID is the difference between the original cash proceeds and the amount of the note upon maturity. The Note is originally recorded for the proceeds received. The OID is expensed into interest expense pro-rata over the term of the Note, and upon maturity, the Note shall equal the proceeds due.
Share-Based Payments	'
	Generally, all forms of share-based payments, including stock option grants, warrants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on estimated number of awards that are ultimately expected to vest.  Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments are recorded as a component of general and administrative expense.
Earnings per Share	'
	Basic earnings (loss) per share is computed by dividing net income (loss) by weighted average number of shares of common stock outstanding during each period.  Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.
	Prior to the issuance of the Company’s Preferred Stock during the calendar year ending September 30, 2013, the Company did not have any dilutive securities.  As such, a separate computation of diluted earnings (loss) per share was not presented. Commencing with the issuance of the Preferred Stock, the Company now has dilutive securities, and a separate computation of diluted earnings (loss) per share is now presented.
	The Company had the following potential common stock equivalents at December 31, 2013 and September 30, 2013:
			31-Dec-13		September
					30, 2013
	Warrants (1)			7,894,737		7,894,737
	Convertible debt (1)			7,852,782,286
	Total common stock equivalents (2)			7,876,382,587		98,955,822
	(1)    The potential shares for which these instruments can convert into common stock currently exceed the Company’s authorized shares for common stock.  The Company has identified a debt and warrant holder who cannot exceed ownership in the Company by 9.99%.  The investor is limited to 10,960,702 shares on a fully diluted basis, which is the Company’s maximum exposure at the balance sheet date.
	(2)    There are other warrant holders included in total warrants besides those described in note (1) above.
Fair Value of Financial Instruments	'
	The carrying amounts of the Company’s short-term financial instruments, other receivables, accounts payable and accrued liabilities, approximate fair value due to the relatively short period to maturity for these instruments.
Foreign Currency Transactions	'
	The Company’s functional currency is the Canadian Dollar.  The Company’s reporting currency is the U.S. Dollar.  All transactions initiated in Canadian Dollars are translated to U.S. Dollars in accordance with ASC 830-10-20 “Foreign Currency Translation” as follows:
	(i)	Monetary assets and liabilities at the rate of exchange in effect at the balance sheet date;
	(ii)	Equity at historical rates; and
	(iii)	Revenue and expense items at the average exchange rate prevailing during the period.
	Adjustments arising from such translations are deferred until realization and are included as a separate component of stockholders’ equity (deficit) as a component of comprehensive income (loss).  Therefore, translation adjustments are not included in determining net income (loss) but reported as other comprehensive income (loss).
	For foreign currency transactions, the Company translates these amounts to the Company’s functional currency at the exchange rate effective on the invoice date.  If the exchange rate changes between the time of purchase and the time actual payment is made, a foreign exchange transaction gain or loss results which is included in determining net income for the period.
Comprehensive Income (Loss)	'
	Comprehensive income or loss is comprised of net earnings or loss and other comprehensive income or loss, which includes certain changes in equity, excluded from net earnings, primarily foreign currency translation adjustments.
Foreign Country Risks	'
	The Company may be exposed to certain risks as its operations are being conducted in Canada.  The Company’s results may be adversely affected by change in the political and social conditions in Canada due to governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversions and remittances abroad, and rates and methods of taxation, among other things.  The Company does not believe these risks to be significant, and no such losses have occurred in the current or prior periods because of these factors.  However, there can be no assurance those changes in political and other conditions will not result in any adverse impact in future periods.
Recent Accounting Pronouncements	'
	In May 2011, the FASB issued ASU No. 2011-04, Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. The guidance in ASU 2011-04 changes the wording used to describe the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements, including clarification of the FASB's intent about the application of existing fair value and disclosure requirements and changing a particular principle or requirement for measuring fair value or for disclosing information about fair value measurements. The amendments in this ASU should be applied prospectively and are effective for interim and annual periods beginning after December 15, 2011. Early adoption by public entities is not permitted. The adoption of this guidance is not expected to have a material impact on the Company’s financial position or results of operations.
	In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income. The guidance in ASU 2011-05 applies to both annual and interim financial statements and eliminates the option for reporting entities to present the components of other comprehensive income as part of the statement of changes in stockholders' equity. This ASU also requires consecutive presentation of the statement of net income and other comprehensive income. Finally, this ASU requires an entity to present reclassification adjustments on the face of the financial statements from other comprehensive income to net income. The amendments in this ASU should be applied retrospectively and are effective for fiscal year, and interim periods within those years, beginning after December 15, 2011. The Company has adopted this guidance in these financial statements.

2_Nature_of_Operations_and_Sum2

2. Nature of Operations and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Potential common stock equivalents	'
	The Company had the following potential common stock equivalents at December 31, 2013 and September 30, 2013:
		31-Dec-13		September
				30, 2013
	Warrants (1)		7,894,737		7,894,737
	Convertible debt (1)		7,852,782,286
	Total common stock equivalents (2)		7,876,382,587		98,955,822

4_Fair_Value_of_Financial_Asse1

4. Fair Value of Financial Assets and Liabilities (Tables)	3 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Company's derivative liability measured at fair value on a recurring basis	'
	The following is the Company’s derivative liability measured at fair value on a recurring basis at:
		31-Dec-13		30-Sep-13
	Level 1	$	-	$	-
	Level 2 – Derivative Liability		48,939		1,337,315
	Level 3		-		-
	Total	$	48,939	$	1,337,315

6_Property_and_Equipment_Table

6. Property and Equipment (Tables)	3 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property and equipment	'
	Property and equipment consists of the following:
		31-Dec-13			30-Sep-13			Estimated Useful Lives
	Software	$	-		$	1,380,876			3
	Leasehold improvements (1)		144,802			144,802			10
	Lab equipment (2)		106,062			106,705			10
	Office equipment		37,336			37,336			5
			288,843			1,669,719
	Less: Accumulated depreciation		(97,809	)		(435,125	)
	Less: Impairment		-			(1,035,027	)
	Property and equipment – net	$	191,034		$	199,567
Lab equipment purchased from an entity controlled by the Company's Chief Executive Officer	'
	The Company purchased $104,122 of lab equipment from an entity controlled by the Company’s former Chief Executive Officer during fiscal years ended 2010 and 2011 as follows:
	2010	$	79,765
	2011		24,357
		$	104,122

7_Notes_Payable_Tables

7. Notes Payable (Tables)	3 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Company's related party liabilities	'
	The following is a summary of the Company’s related party liabilities:
			31-Dec-13			30-Sep-13
	Notes payable (1)		$	20,915		$	20,915
	Advances (2)			7,226			7,226
	Less: payments			(968	)		(968	)
	Total related party liabilities		$	27,173		$	27,173
Debt issue costs	'
	In connection with the issuance of the $300,000 note discussed above, the Company incurred debt issue costs as follows:
	·	8% cash – which is equivalent to $24,000, and
	·	8% warrants – having a fair value of $26,901, which was computed as follows;
			Commitment Date
	Expected dividends			0%
	Expected volatility			180%
	Expected term: conversion feature		2 years
	Risk free interest rate			1.73%
	In January 2012, we raised an additional $22,000 as discussed above, and the Company incurred debt issue costs as follows:
	·	8% cash – which is equivalent to $1,760, and
	·	8% warrants – having a fair value of $154, which was computed as follows;
			Commitment Date
	Expected dividends			0%
	Expected volatility			364%
	Expected term: conversion feature		2 years
	Risk free interest rate			0.65%
	The debt issue costs have been capitalized and are being amortized over the life of the note.
	Debt issue costs paid, September 30, 2011		$	50,901
	Amortization of debt issue costs, September 30, 2011			(11,833	)
	Amortization of debt issue costs, September 30, 2012			(9,833	)
	Amortization of debt issue costs, September 30, 2013			(13,199	)
	Amortization of debt issue costs, December 31, 2012			(3,577
	Debt issue costs - net		$	12,406

10_Stockholders_Equity_Deficit

10. Stockholders Equity (Deficit) (Tables)	3 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Company's warrants outstanding and exercisable	'
	The following is a summary of the Company’s warrants that are outstanding and exercisable at December 31, 2012 and 2011:
				Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years
								Intrinsic Value
		Warrants
	Balance – September 30, 2011		1,074,000	$	0.3		1.27	$	8,560
	Granted		-		-		-		-
	Forfeited/Cancelled		-		-		-		-
	Exercised		-		-
	Balance – December 31, 2012 - outstanding		1,074,000	$	0.3		0.52	$	-
	Balance – December 31, 2012 - exercisable		1,074,000	$	0.3		0.52	$	-

11_Derivative_Liabilities_Tabl

11. Derivative Liabilities (Tables)	3 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative liability	'
	As a result of the application of ASC No. 815, the fair value of the conversion feature is summarized as follows:
	Derivative liability balance at September 30, 2013	$	1,337,315
	Derivative liability Fair value at the commitment date for convertible notes issued
	Fair value mark to market adjustment – December 31, 2013		(1,052,177
	Derivative liability associated with new issuances through December 31, 2013		(2,340,552	)
	Derivative liability balance at December 31, 2013	$	49,939
Fair value at the commitment and remeasurement dates based upon management assumptions	'
	The fair value at the commitment and remeasurement dates were based upon the following management assumptions:
		23-Feb-11			31-Dec-12
		Commitment Date			Remeasurement Date
	Expected dividends		0%		0%
	Expected volatility		180%		298%
	Expected term: conversion feature	4 years			2.65 years
	Risk free interest rate		1.73%		0.25%

12_Other_Related_Party_Transac1

12. Other Related Party Transactions (Tables)	3 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Consulting and rental fees	'
	The Company accrues consulting and rental fees to its former Chief Executive Officer as follows:
	Balance at September 30, 2013 and December 31, 2013	$	415,719

2_Nature_of_Operations_and_Sum3

2. Nature of Operations and Summary of Significant Accounting Policies (Details)	3 Months Ended	12 Months Ended
	Dec. 31, 2013	Sep. 30, 2012
Total common stock equivalents	7,876,382,587	98,955,822
Warrants	'	'
Total common stock equivalents	7,894,737	7,894,737
Convertible Debt	'	'
Total common stock equivalents	7,852,782,286	'

3_Going_Concern_Details_Narrat

3. Going Concern (Details Narrative) (USD $)	3 Months Ended		12 Months Ended
	Dec. 31, 2013	Sep. 30, 2006	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2009	Sep. 30, 2008	Sep. 30, 2007
Going Concern Details Narrative	'	'	'	'	'	'	'	'	'
Net loss	$780,607	($2,631)	($2,421,145)	$694,279	($3,024,617)	($351,790)	($19,076)	($18,199)	($16,960)
Working capital deficit	1,457,525	'	'	'	'	'	'	'	'
Deficit accumulated during the development stage	$4,379,522	'	'	'	'	'	'	'	'

4_Fair_Value_of_Financial_Asse2

4. Fair Value of Financial Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Derivative liability measured at fair value on a recurring basis	$48,939	$1,337,315
Level 1	'	'
Derivative liability measured at fair value on a recurring basis	'	'
Level 2 Derivative Liability	'	'
Derivative liability measured at fair value on a recurring basis	48,939	1,337,315
Level 3	'	'
Derivative liability measured at fair value on a recurring basis	'	'

5_Other_Receivables_Details_Na

5. Other Receivables (Details Narrative) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Other Receivables Details Narrative	'	'
Other receivables	$3,194	$3,194

6_Property_and_Equipment_Detai

6. Property and Equipment (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Property And Equipment Details	'	'
Software (3 Year Useful Life)	'	$1,380,876
Leasehold improvements (10 Year Useful Life)	144,802	144,802
Lab equipment (10 Year Useful Life)	106,062	106,705
Office equipment (5 Year Useful Life)	37,336	37,336
Property and equipment b gross	288,843	1,669,719
Less: Accumulated depreciation	-97,809	-435,125
Less: Impairment	'	1,035,027
Property and equipment b net	$191,034	$199,567

6_Property_and_Equipment_Detai1

6. Property and Equipment (Details 1) (USD $)	Dec. 31, 2013
Property And Equipment Details	'
2010	$79,765
2011	24,357
Total	$104,122

7_Notes_Payable_Details

7. Notes Payable (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Notes Payable Details	'	'
Notes payable	$20,915	$20,915
Advances	415,719	415,719
Less: payments	-968	-968
Total related party liabilities	$27,173	$27,173

7_Notes_Payable_Details_1

7. Notes Payable (Details 1)	3 Months Ended
	Dec. 31, 2013
Warrants associated with $300,000 note	'
Expected dividends	0.00%
Expected volatility	180.00%
Expected term: conversion feature	'2 years
Risk free interest rate	1.73%
Additional financing $22,000	'
Expected dividends	0.00%
Expected volatility	364.00%
Expected term: conversion feature	'2 years
Risk free interest rate	0.65%

7_Notes_Payable_Details_2

7. Notes Payable (Details 2) (USD $)	3 Months Ended
	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2013
Notes Payable Details 2	'	'	'	'	'
Debt issue costs paid	'	'	'	$50,901	'
Amortization of debt issue costs	-13,199	-3,577	-9,833	-11,833	'
Debt issue costs - net	'	'	'	'	$12,406

7_Notes_Payable_Details_Narrat

7. Notes Payable (Details Narrative) (USD $)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Notes Payable Details Narrative	'	'
Debt converted into common stock	$34,790	'
Debt discounts	$170,000	$165,000

9_Stockholders_Equity_Deficit_

9. Stockholders Equity (Deficit) (Details) (USD $)	27 Months Ended
	Dec. 31, 2013
Number of Warrants	'
Number of Warrants Outstanding	1,074,000
Number of Warrants Exercisable	1,074,000
Weighted Average Exercise Price	'
Weighted Average Exercise Price Forfeited/canceled	'
Weighted Average Exercise Price Outstanding, Ending	$0.30
Weighted Average Exercise Price Exercisable	$0.30
Weighted Average Remaining Contractual Life (in years)	'
Weighted Average Remaining Contractual Life (in years) Outstanding, Beginning	'1 year 3 months 7 days
Weighted Average Remaining Contractual Life (in years) Exercisable	'6 months 7 days
Aggregate Intrinsic Value	'
Aggregate Intrinsic Value Outstanding, beginning	$8,560
Aggregate Intrinsic Value Outstanding, ending	'

10_Derivative_Liabilities_Deta

10. Derivative Liabilities (Details) (USD $)	3 Months Ended
	Dec. 31, 2013	Sep. 30, 2013
Derivative liability balance at September 30, 2012	'	'
Derivative liability Fair value at the commitment date for convertible notes issued	'	$1,337,315
Fair value mark to market adjustment	-1,052,177	'
Derivative liability associated with new issuances	-2,340,552	'
Derivative liability balance	'	$49,939

10_Derivative_Liabilities_Deta1

10. Derivative Liabilities (Details 1)	3 Months Ended
	Dec. 31, 2013
Commitment Date	'
Expected dividends	0.00%
Expected volatility	180.00%
Expected term: conversion feature	'4 years
Risk free interest rate	1.73%
Remeasurement Date	'
Expected dividends	0.00%
Expected volatility	298.00%
Expected term: conversion feature	'2 years 7 months 24 days
Risk free interest rate	0.25%

11_Other_Related_Party_Transac

11. Other Related Party Transactions (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
Other Related Party Transactions Details	'	'
Accounts payable - related party, Beginning	$415,719	$415,719
Accounts payable - related party, End	$415,719	$415,719